Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study
- Soham D. Puvvada
- , José M. Guillén-Rodríguez
- , Jessica Yan
- , Lora Inclán
- , Kara Heard
- , Xavier I. Rivera
- , Faiz Anwer
- , Daruka Mahadevan
- , Jonathan H. Schatz
- , Daniel O. Persky
Research output: Contribution to journal › Article › peer-review
16
Link opens in a new tab
Scopus
citations